AN2 Therapeutics

ANTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$182.266 M

$4.83 -2.62%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$35.2M

Loss-making

Shares outstanding

37,736,237

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#272Satellos BioscienceMSLE$188.2M
#273NovaBridge BiosciencesNBP$183.5M
#274AN2 TherapeuticsANTX$182.3M
#275Minerva NeurosciencesNERV$181.9M
#276Tonix PharmaceuticalsTNXP$181.6M

What if AN2 Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$801,191.96

Per share 165,878× higher

Bitcoin $1.74T

$46,153.38

Per share 9,556× higher

Nvidia $5.52T

$146,166.32

Per share 30,262× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for AN2 Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.